JPWO2021033773A1 - - Google Patents
Info
- Publication number
- JPWO2021033773A1 JPWO2021033773A1 JP2021540992A JP2021540992A JPWO2021033773A1 JP WO2021033773 A1 JPWO2021033773 A1 JP WO2021033773A1 JP 2021540992 A JP2021540992 A JP 2021540992A JP 2021540992 A JP2021540992 A JP 2021540992A JP WO2021033773 A1 JPWO2021033773 A1 JP WO2021033773A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962890053P | 2019-08-21 | 2019-08-21 | |
| US62/890,053 | 2019-08-21 | ||
| PCT/JP2020/031672 WO2021033773A1 (ja) | 2019-08-21 | 2020-08-21 | Ａｂｃｃ１１阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021033773A1 true JPWO2021033773A1 (https=) | 2021-02-25 |
| JP7440934B2 JP7440934B2 (ja) | 2024-02-29 |
Family
ID=74659662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540992A Active JP7440934B2 (ja) | 2019-08-21 | 2020-08-21 | Ａｂｃｃ１１阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220288038A1 (https=) |
| EP (1) | EP4019048A4 (https=) |
| JP (1) | JP7440934B2 (https=) |
| CN (1) | CN114341120A (https=) |
| WO (1) | WO2021033773A1 (https=) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007148835A1 (ja) * | 2006-06-22 | 2007-12-27 | Nippon Chemiphar Co., Ltd. | 抗ガン剤耐性克服剤 |
| WO2018023126A1 (en) * | 2016-07-29 | 2018-02-01 | Kaspar Roger L | Methods of treating osmidrosis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2092580T3 (es) | 1990-11-30 | 1996-12-01 | Teijin Ltd | Derivado de 2-ariltiazol y composicion farmaceutica que contiene el mismo. |
| EP1206937B1 (en) * | 1999-07-16 | 2008-01-23 | Shoei Co., Ltd. | Nitroimidazole external preparations for the treatment of atopic dermatitis |
| DE10352511A1 (de) * | 2003-11-07 | 2005-06-16 | Ernst-Moritz-Arndt-Universität Greifswald | Verwendung von MRP4-Inhibitoren zur Behandlung und/oder Prophylaxe kardiovaskulärer Erkrankungen |
| WO2007018687A1 (en) * | 2005-07-21 | 2007-02-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| CN102093309B (zh) * | 2006-12-07 | 2012-07-04 | 重庆医药工业研究院有限责任公司 | 非布司他的晶型及其制备方法 |
| DE102008001811A1 (de) * | 2008-05-15 | 2009-11-19 | Beiersdorf Ag | Kosmetische Zubereitungen zur Verminderung von Schweißgeruch mit ABCC-Modulatoren |
| EP2582683B1 (en) * | 2010-06-15 | 2018-03-21 | Ardea Biosciences, Inc. | Treatment of gout and hyperuricemia |
| WO2012122532A2 (en) * | 2011-03-09 | 2012-09-13 | Biocryst Pharmaceuticals, Inc. | Compositions and methods for treatment of hyperuricemia |
| CN105399694B (zh) * | 2015-12-11 | 2017-09-15 | 浙江京新药业股份有限公司 | 药物Lesinurad轴手性对映体 |
| CN105949156A (zh) * | 2016-05-15 | 2016-09-21 | 刘雨 | 一种伊曲康唑的药物组合物及其医药用途 |
-
2020
- 2020-08-21 US US17/636,151 patent/US20220288038A1/en not_active Abandoned
- 2020-08-21 CN CN202080058788.5A patent/CN114341120A/zh active Pending
- 2020-08-21 JP JP2021540992A patent/JP7440934B2/ja active Active
- 2020-08-21 EP EP20854802.4A patent/EP4019048A4/en not_active Withdrawn
- 2020-08-21 WO PCT/JP2020/031672 patent/WO2021033773A1/ja not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007148835A1 (ja) * | 2006-06-22 | 2007-12-27 | Nippon Chemiphar Co., Ltd. | 抗ガン剤耐性克服剤 |
| WO2018023126A1 (en) * | 2016-07-29 | 2018-02-01 | Kaspar Roger L | Methods of treating osmidrosis |
Non-Patent Citations (4)
| Title |
|---|
| EL-SHEIKH, AAK, ET AL.: "Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug re", BRITISH JOURNAL OF PHARMACOLOGY, vol. 155, JPN6020034769, 25 August 2008 (2008-08-25), pages 1066 - 1075, ISSN: 0005133468 * |
| KEPPLER, DIETRICH: "Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy", HANDBOOK OF EXPERIMENTAL PHARMACOLOGY, vol. 201, JPN6020034774, 26 October 2010 (2010-10-26), pages 299 - 323, XP009534139, ISSN: 0005029546, DOI: 10.1007/978-3-642-14541-4_8 * |
| SHEN, ZANCONG, ET AL.: "In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor", CLIN. DRUG INVESTIG., vol. 36, JPN6020034770, 7 March 2016 (2016-03-07), pages 443 - 452, ISSN: 0005133469 * |
| ZHE-SHENG CHEN ET AL.: ""Transport of Bile Acids, Sulfated Steroids, Estradiol 17-β-d-Glucuronide, and Leukotriene C4 by H", MOLECULAR PHARMACOLOGY, vol. 67, no. 2, JPN6023034175, 10 November 2004 (2004-11-10), pages 545 - 557, ISSN: 0005133466 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220288038A1 (en) | 2022-09-15 |
| EP4019048A4 (en) | 2023-10-04 |
| CN114341120A (zh) | 2022-04-12 |
| WO2021033773A1 (ja) | 2021-02-25 |
| EP4019048A1 (en) | 2022-06-29 |
| JP7440934B2 (ja) | 2024-02-29 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220208 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230404 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230602 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230822 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231017 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240116 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240208 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7440934 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |